Integrin Receptor Antagonist class drugs

1 result
Takeda Pharmaceuticals America, Inc.
Usage: ENTYVIO is indicated for adults with moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn's disease (CD).